by Team Small News | May 13, 2025 | Pharma, Sun Pharma
The pharmaceutical sector is facing uncertainty after US President Donald Trump signed an executive order on May 12, requiring US drug companies to align their prices with those in other developed countries. This move could have a significant negative impact on the...
by Team Small News | May 9, 2025 | Pharma, Sun Pharma
Sun Pharmaceutical Industries (Sun Pharma) has launched a corporate brand campaign titled “Touching 1,000 Lives Every Minute” to highlight its role in supporting patients, caregivers, doctors, pharmacists, and communities. The campaign showcases the...
by Team Small News | May 6, 2025 | Pharma, Sun Pharma
Sun Pharmaceutical Industries Ltd. is a prominent player in the Indian pharmaceutical industry. The company’s product portfolio is diverse, with a focus on generic and over-the-counter (OTC) medicines, which account for approximately 94% of its net sales. These...
by Team Small News | Apr 30, 2025 | Pharma, Sun Pharma
Dilip Shanghvi, the 69-year-old chairman and managing director of Sun Pharma, India’s largest pharmaceutical company, reflects on his 42-year journey of building the company from scratch. With a current market capitalization of ₹410,670 crore and a net cash...
by Team Small News | Apr 27, 2025 | Pharma, Sun Pharma
Sun Pharmaceutical Industries Ltd., India’s largest pharmaceutical company, has announced promising results from a clinical trial for MM-II, a new non-opioid therapy for knee osteoarthritis pain relief. The trial, conducted in partnership with Moebius Medical,...
by Team Small News | Apr 25, 2025 | Pharma, Sun Pharma
Sun Pharmaceutical Industries and Moebius Medical have announced promising results from a Phase II clinical trial for their investigational osteoarthritis treatment, MM-II. The study demonstrated significant improvements in pain reduction and functional improvement in...